intermittent fasting and glp-1 Danger! The truth about on a Dietary impact on fasting and

A trial in 150 participants with either ovarian cancer or castration-resistant prostate cancer found no evidence that ALCAR (1g every 3 days) given with the anticancer drug sagopilone (for up to six cycles of treatment) reduced the overall risk of peripheral neuropathy compared to a placebo (90)

There are many potential modalities in which GLP-1 can serve a role in protecting against the progression of AD

Clinical utility of measurements of insulin-like growth factor 1

Microbial tryptophan catabolites in health and disease

Documentation and pre-order guidance are available when labs need additional planning context